Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Atherosclerosis

• Publication date

  1982-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0021-9150(82)90153-8PMID 6951582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on serum lipoproteins and lipid metabolism. Analysis of a random sample of 40 year old men.

  1980cited by this paper
• Effect of blood viscosity decrease on exercise ST segment depressions in hyperlipidemia.

  1980cited by this paper
• The relation between plasma fibrinogen, blood hematocrit and exercise ST segment depressions in hyperlipoproteinemia.

  1980cited by this paper
• The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.

  1979cited by this paper
• Effect of hypolipidemic drugs on serum lipoproteins.

  1979cited by this paper
• Effect of hypolipidemic drugs on serum lipoproteins.

  1979cited by this paper
• DOSE-RESPONSE STUDY OF BEZAFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINAEMIA

  1978cited by this paper
• Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.

  1978cited by this paper
• One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.

  1978cited by this paper
• Lipoprotein fractionation.

  1973cited by this paper
• Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods

  1973cited by this paper
• Classification of hyperlipidaemias and hyperlipoproteinaemias.

  1970cited by this paper
• A colorimetric method for estimating serum triglycerides.

  1968cited by this paper
• A new method for the direct determination of serum cholesterol.

  1953cited by this paper

• Use of fibrates in the metabolic syndrome: A review.

  2016cites this paper
• Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.

  2000cites this paper
• Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.

  1996cites this paper
• Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.

  1996cites this paper
• Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate.

  1996cites this paper
• Effect of ciprofibrate in patients with primary hypercholesterolemia: a 6-year pilot study

  1995cites this paper
• Zur Pharmakokinetik von Lipidsenkern, 10. Mitt. : Zweiter Beitrag zur Frage der Dehalogenierung des Lipidsenkers Ciprofibrat

  1994cites this paper
• [The pharmacokinetics of hypolipemic agents. 10. The dehalogenation of the hypolipemic agent ciprofibrate].

  1994cites this paper
• Effects of ciprofibrate on LDL metabolism in man.

  1994cites this paper
• Drug interactions with fibric acids.

  1994cites this paper
• The effects of fibrates on lipoprotein and hemostatic coronary risk factors.

  1994cites this paper
• Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia.

  1993cites this paper
• Tolerability of fibric acids. Comparative data and biochemical bases.

  1992cites this paper
• Comparison of simvastatin and ciprofibrate in the treatment of primary hypercholesterolaemia — a French multicentre study

  1992cites this paper
• Lipid lowering drugs.

  1990cites this paper
• Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.

  1988cites this paper
• Effects of fibrates on serum lipids and atherosclerosis.

  1988cites this paper
• Effect of fibric acid derivatives on blood lipid and lipoprotein levels.

  1987cites this paper
• The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

  1987cites this paper
• Effect of Ciprofibrate on Platelet Aggregation and Fibrinolysis in Patients with Hypercholesterolaemia

  1985cites this paper
• Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent.

  1985cites this paper
• Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.

  1985cites this paper
• Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B.

  1985cites this paper
• Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia

  1984cites this paper
• Drugs affecting lipid metabolism

  1984cites this paper